Accuracy of in vivo multimodal optical imaging for detection of oral neoplasia

Cancer Prevention Research

Volumn 5, Issue 6, 2012, Pages 801-809

  Pierce, Mark C ^a,c   Schwarz, Richard A ^a   Bhattar, Vijayashree S ^b   Mondrik, Sharon ^a   Williams, Michelle D ^b   Lee, J Jack ^b   Richards Kortum, Rebecca ^a   Gillenwater, Ann M ^b  

^a Rice University   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER; PROFLAVINE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; IN VIVO STUDY; LEUKOPLAKIA; MALE; MICROSCOPY; MOUTH CANCER; MULTIMODAL OPTICAL IMAGING SYSTEM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSTIC IMAGING; FEMALE; FIBER OPTIC TECHNOLOGY; FLUORESCENCE; HUMANS; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY;

EID: 84866449932     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0555     Document Type: Article

References (37)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010.
2. Chen AY, Myers JN. Cancer of the oral cavity. Dis Mon 2001;47:275-361.
3. Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 2008;44:10-22. (Pubitemid 350258631)
4. Thomson PJ. Field change and oral cancer: new evidence for widespread carcinogenesis? Int J Oral Maxillofac Surg 2002;31:262-6.
5. De Veld DC, Witjes MJ, Sterenborg HJ, Roodenburg JL. The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol 2005;41:117-31. (Pubitemid 40202877)
6. Lane PM, Gilhuly T, Whitehead P, Zeng H, Poh CF, Ng S, et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt 2006;11:024006.
7. Roblyer D, Kurachi C, Stepanek V, Williams MD, El-Naggar AK, Lee JJ, et al. Objective detection and delineation of oral neoplasia using autofluorescence imaging. Cancer Prev Res 2009;2:423-31.
8. Poh CF, MacAulay CE, Laronde DM, Williams PM, Zhang L, Rosin MP. Squamous cell carcinoma and precursor lesions: diagnosis and screening in a technical era. Periodontology 2000 2011;57:73-88.
9. Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res 2006;12:6716-22. (Pubitemid 44876840)
10. Poh CF, MacAulay CE, Zhang L, Rosin MP. Tracing the "at-risk" oral mucosa field with autofluorescence: Steps toward clinical impact. Cancer Prev Res 2009;2:401-4.
11. Thomas GT, Lewis MP, Speight PM. Matrix metalloproteinases and oral cancer. Oral Oncol 1999;35:227-33. (Pubitemid 29148354)
12. Müller MG, Valdez TA, Georgakoudi I, Backman V, Fuentes C, Kabani S, et al. Spectroscopic detection and evaluation of morphologic and biochemical changes in early human oral carcinoma. Cancer 2003;97:1681-92. (Pubitemid 36350711)
13. Pavlova I, Williams M, El-Naggar A, Richards-Kortum R, Gillenwater A. Understanding the biological basis of autofluorescence imaging for oral cancer detection: High-resolution fluorescence microscopy in viable tissue. Clin Cancer Res 2008;14:2396-404. (Pubitemid 351551073)
14. Pavlova I, Weber CR, Schwarz RA, Williams M, El-Naggar A, Gillenwater A, et al. Monte Carlo model to describe depth selective fluorescence spectra of epithelial tissue: Applications to diagnosis of oral precancer. J Biomed Opt 2008;13:064012.
15. Scheer M, Neugebauer J, Derman A, Fuss J, Drebber U, Zoeller JE. Autofluorescence imaging of potentially malignant mucosa lesions. Oral Surg Oral Med Oral Path Oral Radiol Endodontol 2011;111:568-77.
16. Awan KH, Morgan PR, Warnakulasuriya S. Evaluation of an autofluorescence based imaging system (VELscope™) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol 2011;47:274-7.
17. Maitland KC, Gillenwater AM, Williams MD, El-Naggar AK, Descour MR, Richards-Kortum RR. In vivo imaging of oral neoplasia using a miniaturized fiber optic confocal reflectance microscope. Oral Oncol 2008;44:1059-66.
18. Haxel BR, Goetz M, Kiesslich R, Gosepath J. Confocal endomicroscopy: A novel application for imaging of oral and oropharyngeal mucosa in human. Eur Arch Otorhinolaryngol 2010;267:443-8.
19. Muldoon TJ, Roblyer D, Williams MD, Stepanek VMT, Richards-Kortum R, Gillenwater AM. Noninvasive imaging of oral neoplasia with a high-resolution fiber-optic microendoscope. Head Neck 2011;34:305-12.
20. Roblyer D, Richards-Kortum R, Sokolov K, El-Naggar AK, Williams MD, Kurachi C, et al. Multispectral optical imaging device for in vivo detection of oral neoplasia. J Biomed Opt 2008;13:024019.
21. Pierce MC, Yu D, Richards-Kortum R. High-resolution fiber-optic microendoscopy for in situ cellular imaging. J Vis Exp 2011;47:e2306.
22. Wainwright M. Acridine-a neglected antibacterial chromophore. J Antimicrobial Chemotherapy 2001;47:1-13.
23. Polglase AL, McLaren WJ, Skinner SA, Kiesslich R, Neurath MF, Delaney PM. A fluorescence confocal endomicroscope for in vivo microscopy of the upper- and lower-GI tract. Gastrointest Endosc 2005;62:686-95. (Pubitemid 41502992)
24. Janssen PA, Selwood BL, Dobson SR, Peacock D, Thiessen PN. To dye or not to dye: A randomized, clinical trial of a triple dye/alcohol regime versus dry cord care. Pediatrics 2003;111:15-20. (Pubitemid 36071027)
25. Barnes L, Eveson JW, Reichart P, Sidransky D, Ed. World Health Organization Classification of tumours. Pathology and genetics of head and neck tumors. Lyon, France: IARC Press; 2005.
26. Thomson PJ, Hamadah O, Goodson ML, Cragg N, Booth C. Predicting recurrence after oral precancer treatment: Use of cell cycle analysis. Br J Oral Maxillo Surg 2008;46:370-5. (Pubitemid 351787378)
27. Torres-Rendon A, Roy S, Craig GT, Speight PM. Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas. Br J Cancer 2009;100:1128-34.
28. Montebugnoli L, Badiali G, Marchetti C. Prognostic value of Ki67 from clinically and histologically 'normal' distant mucosa in patients surgically treated for oral squamous cell carcinoma: a prospective study. Int J Oral Maxillo Surg 2009;38:1165-72.
29. De Oliveira LR, Ribeiro-Silva A, Zucoloto S. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. J Oral Path Med 2007;36:191-7. (Pubitemid 46495983)
30. Lo Muzio L, Campisi G, Farina A, Rubini C, Pastore L, Giannone N, et al. Effect of p63 expression on survival in oral squamous cell carcinoma. Cancer Investigation 2007;25:464-9. (Pubitemid 47450678)
31. Saintigny P, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, et al. ΔNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. Clin Cancer Res 2009;15:6284-91.
32. Moergel M, Abt E, Stockinger M, Kunkel M. Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma. Oral Oncol 2010;46:667-71.
33. Ladstein RG, Bachmann IM, Straume O, Akslen LA. Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma. BMC Cancer 2010;10:140.
34. Uedo N, Iishi H, Tatsuta M, Yamada T, Ogiyama H, Imanaka, et al. A novel videoendoscopy system by using autofluorescence and reflectance imaging for diagnosis of esophagogastric cancers. Gastrointest Endosc 2005;62:521-8. (Pubitemid 41383771)
35. Bradley G, Odell EW, Raphael S, Ho J, Le HW, Benchimol S, et al. Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma. Br J Cancer 2010;103:1432-42.
36. Guillaud M, Zhang L, Poh C, Rosin MP, MacAulay C. Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions. Cancer Res 2008;68:3099-107.
37. Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000;6:357-62. (Pubitemid 30111451)